CBSA: 2013 was successful year for state's bioscience sector

CBSA: 2013 was successful year for state's bioscience sector

DENVER - Colorado bioscience companies realized a number of key financings and acquisitions in 2013, according to the Colorado BioScience Association , an industry support group. "We saw... Read More

By: InnovatioNews Wednesday December 18, 2013 0 comments Tags: April Giles, Biodesix, Clovis Oncology, Denver, Gambro BCT, Inviragen, Lanx, SomaLogic, Surefire Medical

CBSA announces finalists for top awards at 10th anniversary awards dinner Nov. 7 in Denver

CBSA announces finalists for top awards at 10th anniversary awards dinner Nov. 7 in Denver

DENVER - The Colorado BioScience Association announced it has selected the finalists for the 2013 "Company of the Year" and "Rising Star" awards to be presented during CBSA's Annual Awards Dinner... Read More

By: InnovatioNews Tuesday October 29, 2013 0 comments Tags: AlloSource, AmideBio, April Giles, BaroFold, Clovis Oncology, Denver, Medtronic Navigation, Surefire Medical, VetDC

Clovis signs agreement with QIAGEN to develop test for resistance mutation in cancer patients

Clovis signs agreement with QIAGEN to develop test for resistance mutation in cancer patients

BOULDER - Clovis Oncology (Nasdaq: CLVS) has signed an agreement with QIAGEN (Nasdaq: QGEN, Frankfurt Prime Standard: QIA) to develop a companion diagnostic test to identify the T790M... Read More

By: InnovatioNews Tuesday October 22, 2013 0 comments Tags: Boulder, Clovis Oncology, Patrick J.Mahaffy, QIAGEN, therascreen

Colorado CEOs to keynote 2013 Rocky Mountain Life Science Investor and Partnering Conference

Colorado CEOs to keynote 2013 Rocky Mountain Life Science Investor and Partnering Conference

DENVER - Kyle Lefkoff, founder and general partner of Boulder Ventures, will lead a keynote breakfast conversation with CEOs of Colorado's premier publicly-traded pharmaceutical companies during... Read More

By: InnovatioNews Wednesday September 4, 2013 0 comments Tags: Array BioPharma, Boulder Ventures, Clovis Oncology, Denver, Kyle Lefkoff, Patrick Mahaffey, Ron Squarer

Clovis Oncology reports positive results for ovarian, lung cancer drugs

Clovis Oncology reports positive results for ovarian, lung cancer drugs

BOULDER - Clovis Oncology (Nasdaq: CLVS) announced initial findings from an ongoing study of its ovarian cancer-fighting drug rucaparib showed 89 percent of ovarian cancer patients treated... Read More

By: Steve Wednesday June 5, 2013 0 comments Tags: Boulder, Clovis Oncology, CO-1686, Patrick J.Mahaffy, Rucaparib

Clovis Oncology and Foundation Medicine announce diagnostic collaboration

Clovis Oncology and Foundation Medicine announce diagnostic collaboration

BOULDER - Clovis Oncology Inc. (Nasdaq: CLVS) and Foundation Medicine Inc. today announced they have entered into a collaboration aimed at developing an in-vitro diagnostic (IVD) to identify... Read More

By: Steve Monday August 6, 2012 0 comments Tags: Clovis Oncology, Foundation Medicine, Michael J. Pellini, Patrick J. Mahaffey, Rucaparib